Search
for
Sort by
Research 61–90 of 1000+
- Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease
- COMMENTS ON THE LETTER ON HYPONATREMIA ASSOCIATED WITH DIURETIC USE AND URINARY RETENTION IN AN OLDER MAN
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Distinct mechanisms for sebaceous gland self-renewal and regeneration provide durability in response to injury
- Novel prospectives of shikimic acid and Prunus mume extract for enhancing bioactivity on 5α-reductase and stability in cosmetic patches for acne treatment
- Skin diseases in consequence of endocrine alterations
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Endocrine disorders and hormonal therapy for adolescent acne
- Acne
- Pathologies of the skin and its appendages in endocrine diseases
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Polycystic Ovarian Syndrome in Adolescents
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Retinol-binding protein 4, leptin, and insulin resistance in idiopathic hirsutism and hirsute women with polycystic ovary syndrome
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case